Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Clinical Genetics · X-Linked Immunoneurologic Disorders

Genetics, Testing, and Pinpointing the Diagnosis

At a Glance

Diagnosing an X-linked immunoneurologic disorder may require more than a standard immune panel. Gene testing should consider MAGT1, SH2D1A, XIAP, WAS, and ABCD1, along with deletion analysis and protein or biochemical tests; a normal result or VUS does not settle every case.

Moving from a broad umbrella term like “immunoneurologic disorder” to a precise diagnosis requires specialized testing. Because many of these conditions share symptoms with more common issues—like Common Variable Immunodeficiency (CVID) or Immune Thrombocytopenia (ITP)—it is common for patients to be misdiagnosed for years before the correct genetic cause is found [1][2].

Understanding X-Linked Inheritance

The disorders in this category are X-linked. This means the gene responsible is located on the X chromosome.

  • Why it affects males: Males have one X and one Y chromosome. If their only X chromosome has a mutation, they will have the disorder [3].
  • The role of female carriers: Females have two X chromosomes. A “carrier” usually has one healthy X chromosome that “masks” the mutation on the other. While many carriers have no symptoms, some can experience milder immune or inflammatory issues, or severe symptoms (like adrenal insufficiency in cALD), depending on how their cells use each X chromosome (a process called X-inactivation) [4][5]. Genetic counseling and cascade testing of relatives is crucial.

Key Genes and Targeted Tests

Each disorder under this umbrella is linked to a specific “instruction manual” in your DNA. Pinpointing the diagnosis requires looking at these specific genes and the proteins they create [6].

Condition Gene Involved Key Biomarkers & Functional Tests
XMEN MAGT1 NKG2D expression (on CD8 T cells), intracellular magnesium levels, and transferrin N-glycosylation [7][8][9].
XLP1 SH2D1A SAP protein expression (via flow cytometry) and 2B4/CD244 signaling function [10][11].
XLP2 XIAP (BIRC4) XIAP protein expression and monocyte responses to MDP (a bacterial component) [12][13].
cALD ABCD1 VLCFA (Very-Long-Chain Fatty Acids) levels in the blood, especially C26:0 [14][15].
WAS WAS WASP protein expression and presence of microthrombocytopenia (unusually small platelets) [16][17].

Navigating the Testing Process

When reviewing your lab or pathology reports, look for these specific elements to ensure the evaluation was thorough. These functional tests are specialized and are guided by phenotype and lab availability.

  1. Gene Coverage: Did the panel explicitly test for MAGT1, SH2D1A, XIAP, WAS, and ABCD1? Standard “immune” panels may not always include all of these [18].
  2. Deletion/Duplication Analysis: Sometimes a single “letter” of DNA isn’t wrong, but a whole “page” is missing. Basic sequencing can miss these structural variants, so specific “del/dup” testing is often included in modern panels or ordered separately [2][19].
  3. Protein Expression (Flow Cytometry): Genetic mutations don’t always tell the whole story. Tests like NKG2D surface expression or SAP/XIAP levels show whether the gene is actually working in your cells [7][12].
  4. Platelet Size: In Wiskott-Aldrich Syndrome, it isn’t just the number of platelets that matters, but their size. A report showing microplatelets (low mean platelet volume or MPV) is a major clue that is often missed in general ITP diagnoses [17][20].
  5. Biochemical Ratios: For cALD, the report should list specific VLCFA ratios, such as C24/C22 and C26/C22, rather than just a total fatty acid count [15].

Why a “Normal” Result Might Be Misleading

It is important to know that a “normal” protein test does not always rule out a disease. For example, some people with XLP1 produce the SAP protein, but the protein itself doesn’t function correctly [11]. Similarly, normal VLCFA results are more relevant to some heterozygous female carriers or alternative diagnoses; affected males generally have elevated VLCFA from early life [21]. Also, a Variant of Uncertain Significance (VUS) does not establish or exclude a diagnosis and requires genetics expertise. If a doctor’s suspicion remains high, advanced tools like whole-exome sequencing or RNA studies may be used to find hidden mutations [22][23].

Common questions in this guide

Which genes may be included when testing for an X-linked immunoneurologic disorder?
Testing may include MAGT1 for XMEN, SH2D1A for XLP1, XIAP or BIRC4 for XLP2, ABCD1 for cALD, and WAS for Wiskott-Aldrich syndrome. The appropriate panel depends on the person’s symptoms, laboratory findings, and clinical suspicion.
What does deletion and duplication testing look for?
This testing looks for larger missing or repeated sections of DNA that standard sequencing can miss. Ask whether your evaluation included copy number or structural variant analysis.
Can a normal SAP or other protein test rule out an X-linked disorder?
No. In XLP1, some people produce SAP protein but the protein does not work properly, so a normal amount does not always exclude disease. Genetic results and functional testing should be interpreted together by a specialist.
What does a variant of uncertain significance mean on a genetic report?
A variant of uncertain significance, or VUS, is a DNA change whose medical importance is not yet clear. It does not confirm or exclude an X-linked disorder and should be reviewed with a genetics professional.
Why might a CVID or ITP diagnosis need to be reevaluated?
Some X-linked disorders can resemble Common Variable Immunodeficiency or Immune Thrombocytopenia. Tiny platelets, unusual NKG2D expression, a suggestive family history, or other specialized findings may point to an inherited X-linked disorder and prompt genetic testing.
How does X-linked inheritance affect sons and female relatives?
Males have one X chromosome, so a disease-causing variant on that chromosome can cause the disorder. Females with one altered copy are often carriers, but some develop milder or, in certain conditions, severe symptoms. Genetic counseling and testing of relatives can clarify risks.
What do VLCFA results mean when cALD is being considered?
Affected males with cALD generally have elevated very-long-chain fatty acids from early life, and reports may include C24/C22 and C26/C22 ratios. Results can be interpreted differently in female carriers and other diagnoses, so they need specialist review.

Get notified when new evidence is published on X-linked immunoneurologic disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Novel MAGT1 Mutation Found in the First Chinese XMEN in Hong Kong.

    Au EYL, Tung EKK, Ip RWK, Li PH

    Case reports in immunology 2022; (2022()):2390167 doi:10.1155/2022/2390167.

    PMID: 35198253
  2. 2

    Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

    Madsen M, Sidlow R

    Cureus 2025; (17(8)):e91193 doi:10.7759/cureus.91193.

    PMID: 41018333
  3. 3

    Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease.

    Prince BT, Thielen BK, Williams KW, et al.

    Pediatric health, medicine and therapeutics 2020; (11()):257-268 doi:10.2147/PHMT.S254253.

    PMID: 32801991
  4. 4

    Case Report: Wiskott-Aldrich Syndrome Caused by Extremely Skewed X-Chromosome Inactivation in a Chinese Girl.

    Hou X, Sun J, Liu C, Hao J

    Frontiers in pediatrics 2021; (9()):691524 doi:10.3389/fped.2021.691524.

    PMID: 34307257
  5. 5

    Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.

    Dziadzio M, Ammann S, Canning C, et al.

    Journal of clinical immunology 2015; (35(5)):439-44 doi:10.1007/s10875-015-0166-0.

    PMID: 25943627
  6. 6

    Diagnostic Modalities in Primary Immunodeficiency.

    Raymond LS, Leiding J, Forbes-Satter LR

    Clinical reviews in allergy & immunology 2022; (63(1)):90-98 doi:10.1007/s12016-022-08933-1.

    PMID: 35290615
  7. 7

    An Update on XMEN Disease.

    Ravell JC, Chauvin SD, He T, Lenardo M

    Journal of clinical immunology 2020; (40(5)):671-681 doi:10.1007/s10875-020-00790-x.

    PMID: 32451662
  8. 8

    Atypical Phenotype of Predominant Autoimmune Cytopenia and Impaired Perforin Expression in XMEN Syndrome.

    Grombirikova H, Markocsy A, Kocurkova A, et al.

    Journal of immunology research 2025; (2025()):3161910 doi:10.1155/jimr/3161910.

    PMID: 41141376
  9. 9

    Case Report: Novel MAGT1 pathogenic variant with significant atopy, hypogammaglobulinemia and viral skin infections.

    Gunderman L, Ptak CP, Schutt M, et al.

    Frontiers in immunology 2026; (17()):1754394 doi:10.3389/fimmu.2026.1754394.

    PMID: 41777878
  10. 10

    Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report.

    Lyu X, Guo Z, Li Y, et al.

    BMC medical genetics 2018; (19(1)):60 doi:10.1186/s12881-018-0576-y.

    PMID: 29649976
  11. 11

    Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.

    Torralba-Raga L, Tesi B, Chiang SCC, et al.

    Pediatric blood & cancer 2020; (67(4)):e28184 doi:10.1002/pbc.28184.

    PMID: 31994322
  12. 12

    Comprehensive flow cytometry-based diagnosis of XIAP deficiency.

    Tomomasa D, Nishimura M, Ohya A, et al.

    Clinical and experimental immunology 2025; (219(1)) doi:10.1093/cei/uxaf020.

    PMID: 40128104
  13. 13

    Rapid flow cytometric diagnosis of XIAP deficiency.

    Wakatsuki R, Nishimura M, Tomomasa D, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(1)):e70284 doi:10.1111/pai.70284.

    PMID: 41556306
  14. 14

    Initial frontal lobe involvement in adult cerebral X-linked adrenoleukodystrophy.

    Jiang W, Jin W, Zhao H, et al.

    Acta neurologica Belgica 2023; (123(6)):2259-2268 doi:10.1007/s13760-023-02295-x.

    PMID: 37247117
  15. 15

    X-linked Adrenoleukodystrophy, The Tunisian Experience.

    Nasrallah F, Kraoua I, Zidi W, et al.

    Clinical laboratory 2015; (61(10)):1531-6 doi:10.7754/clin.lab.2015.150318.

    PMID: 26642716
  16. 16

    WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.

    Sasahara Y

    Pediatrics international : official journal of the Japan Pediatric Society 2016; (58(1)):4-7 doi:10.1111/ped.12819.

    PMID: 26331277
  17. 17

    Identification of a novel nonsense mutation (c.1369 C > T) in the WAS gene in a neonate: a case report and literature review.

    Deng S, Liu X, Chen S, et al.

    BMC pediatrics 2026; (26(1)).

    PMID: 41928123
  18. 18

    Whole Genome Sequencing in 25 Families with Suspected Inborn Errors of Immunity: Diagnostic Yield and Clinical Relevance of Genome-wide Analysis.

    Lee JK, Jang JH, Kim DR, et al.

    Journal of clinical immunology 2025; (45(1)):170.

    PMID: 41275043
  19. 19

    Droplet digital PCR for identifying copy number variations in patients with primary immunodeficiency disorders.

    Woon ST, Mayes J, Quach A, et al.

    Clinical and experimental immunology 2022; (207(3)):329-335 doi:10.1093/cei/uxab034.

    PMID: 35553639
  20. 20

    Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report.

    Glanzmann B, Möller M, Schoeman M, et al.

    BMC medical genetics 2020; (21(1)):124 doi:10.1186/s12881-020-01054-6.

    PMID: 32503528
  21. 21

    Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies

    Ryalls MR, Gan HW, Davison JE

    Journal of clinical research in pediatric endocrinology 2021; (13(2)):212-217 doi:10.4274/jcrpe.galenos.2020.2020.0214.

    PMID: 32394691
  22. 22

    Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity.

    Giardino G, Di Matteo G, Giliani S, et al.

    The Journal of allergy and clinical immunology 2025; (155(4)):1149-1160 doi:10.1016/j.jaci.2024.11.030.

    PMID: 39622296
  23. 23

    Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome.

    Toriello E, Maritato R, De Rosa A, et al.

    Frontiers in immunology 2025; (16()):1517347 doi:10.3389/fimmu.2025.1517347.

    PMID: 39917307

This page explains X-linked inheritance and specialized testing for informational purposes only and does not constitute medical advice. A clinical geneticist or relevant specialist should interpret your results and guide family testing.

Guide contents X-linked immunoneurologic disorder
Research & Literature
02 Symptoms, Variability, and Emergency Red Flags 04 Specific Condition Deep-Dive